“We are currently experiencing a promising trend, particularly in fine chemicals. Moreover, we anticipate stronger demand from the agrochemical industry. We are well prepared for this, thanks also to the recent capacity expansion at our pilot facility,” said Dr. Torsten Derr, CEO of Saltigo GmbH, Leverkusen, outlining his forecasts for 2019. He continued: “In view of the continuing difficulty in the economic environment, especially in the agrochemical sector, we are pleased 2019 started with strong project business.”

The wholly owned subsidiary of specialty chemicals company LANXESS is therefore optimistic about Chemspec Europe.
The 34th international trade fair for fine and specialty chemicals will be held in Basel, Switzerland, from June 26 to 27, 2019.

High-performance network of infrastructure, production and environmental management

The company, which specializes in the exclusive synthesis of chemical active ingredients and intermediates, has a state-of-the art production base at its integrated facilities in Leverkusen and Dormagen, a broad technology portfolio, impressive process development expertise and many years of industry experience in agrochemistry, pharmaceuticals and the fine chemistry sector.

“The integrated production network and its seamless inclusion in the high-performance and reliable supply and disposal infrastructure of one of Europe’s biggest chemical parks are major advantages for our location. Our customers benefit from these advantages in the form of high flexibility as well as delivery reliability and punctuality,” explained Andreas Klein, Head of Marketing & Sales at Saltigo.

Responsibility creates trust

The utmost levels of plant and work safety, high environmental standards and the sustainable use of resources are essential requirements for chemical production in the heart of Europe recognized not just by the authorities but by the public as well. “We are aware of the responsibility this entails, and we take this very seriously. In my mind, this is a key decision-making factor for our established and future customers,” explained Derr.  

These efforts therefore directly benefit customers, and not just in the sense of dependable project management. They also protect customers from a loss of image, which could arise from interruptions or accidents in their suppliers’ production operations.

Attractive to many industries

Saltigo’s comprehensive service range includes process development and optimization in addition to registration and documentation support. This makes Saltigo attractive to companies of various sizes and from a wide range of industries as an exclusive synthesis partner. “We have been practicing professional project management, reliable cooperation and transparent communications throughout all project phases for many years, not to mention systematically protecting our customers’ intellectual property,” summarized Klein.

Saltigo is more than just a producer for the agrochemical and pharmaceutical industries. It also works on products and specialty chemicals for companies in the plastics, personal care and energy industries.

Next to exclusive synthesis, Saltigo also produces and markets the proven insect repellent active ingredient Saltidin (icaridin) to protect against biting insects such as mosquitoes and ticks in addition to a broad range of fine chemical precursors. The latter are now also available to customers all over the world on electronic marketplaces. Saltigo is currently listed on platforms including CheMondis. The company ranks among the world’s leading producers and providers of products such as 1,2,4-triazole, chloroformates and toluidine derivatives.

Further information on the company’s services can be found at www.saltigo.com.

Saltigo GmbH is one of the leading providers in the field of custom synthesis. The company, which is part of the specialty chemicals group LANXESS, belongs to the Advanced Intermediates segment, which earned sales of EUR 2.207 billion in fiscal 2018. Saltigo, which has its corporate headquarters and production facilities in Leverkusen and Dormagen, employs around 1,200 people worldwide.